glp 1 agonist oral drugs glp-1_analogs [TUSOM Lesson: Oral Semaglutide: A New

It has GRAS status as a food additive since 2012

The bio-availability of the DPP-4 inhibitors is very good and the pharmacodynamic- as well as the pharmacokinetic characteristics lead to the above mentioned clinically sufficient DPP-4 inhibition with once daily dosing (only vildagliptin has to be dosed twice daily) (18, 19)

Dietary approaches produce much more modest effects than prescription GLP-1 medications

The safety and tolerability profiles of the GLP-1 RA drug class are consistent across indications and drug class members (Mller et al., 2019

beta-cell failure in diabetes and preservation by clinical treatment

(30,31) Both studies provided compelling evidence that semaglutide use is associated with reduced rates of prosthetic joint infections, sepsis, and hospital readmissions